Malekian Farzaneh, Shamsian Alireza, Kodam Sai Priyanka, Ullah Mujib
Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA, USA.
Molecular Medicine Department of Medicine, Stanford University, Palo Alto, CA, USA.
J Physiol. 2023 Nov;601(22):4853-4872. doi: 10.1113/JP282799. Epub 2022 Jun 2.
Exosomes are membrane-bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter- and intracellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted because of limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non-immunogenicity, and non-toxic nature, as well as their ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are discussed.
外泌体是大多数细胞释放的膜结合囊泡。它们携带核酸、细胞因子、生长因子、蛋白质、脂质和代谢产物。它们负责细胞间和细胞内通讯,其在药物递送中的作用已得到明确界定。外泌体在治疗应用方面具有巨大潜力,但由于分离、纯化和药物递送的标准化程序存在局限性,其临床应用受到限制。外泌体的生物工程可能是实现临床应用标准化和可重复分离的一种方法。由于外泌体体积小、结构稳定、无免疫原性、无毒,以及能够携带多种化合物,因此它们是靶向药物递送的重要载体。外泌体的这些特性可以通过生物工程进一步增强。在本综述中,讨论了外泌体生物工程的可能方法、其生物医学应用和靶向药物递送。